Anti-nephrin antibodies in minimal change disease: Case report series

Key Points

• Autoantibodies were detected in patients with minimal change disease, indicating a potential autoimmune link.
• Treatment with rituximab may offer an alternative for patients who are resistant to standard therapies.
• The study highlights a subgroup of patients with drug-related adverse effects that complicate their condition.
• Findings underscore the need for further investigation into targeted therapies for relapsing disease.